29th July 2022
Reducing human interaction in ELISA
How Automata worked with a UK-based CRO to reduce human steps and...
How Automata worked with a UK-based CRO to reduce human steps and...
John Vincent, Senior Scientist at Medicines Discovery Catapult, discusses why flexible lab...
Rapidly developing breakthrough treatments at pace is critical. We investigate the benefits...